摘要 : Abstract Triptolide (TP), a major active ingredient of Tripterygium wilfordii , exerts potent immunosuppressive effects in the treatment of rheumatoid arthritis but is not widely used in clinical practice due to its multiorgan tox... 展开 Abstract Triptolide (TP), a major active ingredient of Tripterygium wilfordii , exerts potent immunosuppressive effects in the treatment of rheumatoid arthritis but is not widely used in clinical practice due to its multiorgan toxicity, particularly hepatotoxicity, nephrotoxicity, and reproductive toxicity. An LC‐MS/MS approach was employed to explore the endocrine‐disrupting effects of TP. The endocrine‐disrupting effects of various concentrations (0‐100?nM) of TP for 48?hour were firstly investigated using an in vitro model (H295R cell line). It was found that TP did not decrease cell viability. The transcriptional levels of steroidogenic enzymes in H295R cells were assessed by quantificational real‐time polymerase chain reaction. The possible adrenal and endocrine effects of oral administration of TP (0, 50, and 500?μg/kg) for 28 days on both normal and collagen‐induced arthritis (CIA) rats were also explored. The serum and adrenal tissue hormone levels (corticosterone and progesterone) and adrenal histopathology were analyzed, with the results that TP significantly decreased the level of cortisol in H295R cells and the level of plasma corticosterone in both normal and CIA rats. Histological alterations in adrenal cortex were observed at the dose of 500?μg/kg. Exposure to TP for 48?hour had an obvious inhibitory effect on the messenger RNA transcript levels of HSD3B2 , CYP21A2 , CYP17A1 , and CYP11B1 , which is essential for the synthesis of corticosteroids. In a word, TP leads to the disorder of corticosteroid synthesis and secretion, and corticosteroid may be a potential biomarker for the treatment of multiorgan toxicity of TP. 收起